Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$98.98 - $115.74 $935,064 - $1.09 Million
-9,447 Reduced 51.79%
8,793 $1.02 Million
Q2 2023

Aug 11, 2023

BUY
$96.34 - $112.38 $1.25 Million - $1.46 Million
12,976 Added 246.5%
18,240 $1.88 Million
Q1 2023

May 15, 2023

BUY
$107.32 - $113.5 $564,932 - $597,464
5,264 New
5,264 $574,000
Q1 2022

May 13, 2022

SELL
$86.42 - $109.81 $166,358 - $211,384
-1,925 Closed
0 $0
Q4 2021

Feb 09, 2022

BUY
$98.56 - $119.91 $189,728 - $230,826
1,925 New
1,925 $207,000
Q3 2021

Nov 12, 2021

SELL
$91.91 - $110.37 $243,010 - $291,818
-2,644 Closed
0 $0
Q2 2021

Aug 11, 2021

BUY
$86.24 - $95.92 $228,018 - $253,612
2,644 New
2,644 $248,000
Q3 2020

Nov 12, 2020

SELL
$55.23 - $79.93 $487,680 - $705,781
-8,830 Closed
0 $0
Q2 2020

Oct 22, 2020

SELL
$30.2 - $56.98 $1,993 - $3,760
-66 Reduced 0.74%
8,830 $491,000
Q2 2020

Aug 14, 2020

BUY
$30.2 - $56.98 $268,659 - $506,894
8,896 New
8,896 $475,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Baird Financial Group, Inc. Portfolio

Follow Baird Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.